Share-based Payment Arrangement, Expense in USD of INTENSITY THERAPEUTICS, INC. from Q2 2022 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Intensity Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and change rate from Q2 2022 to Q3 2025.
  • Intensity Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2025 was $471K, a 2.48% decline year-over-year.
  • Intensity Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2025 was $2.39M, a 9.73% decline year-over-year.
  • Intensity Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $3.07M, a 120% increase from 2023.
  • Intensity Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1.4M, a 19.6% increase from 2022.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

INTENSITY THERAPEUTICS, INC. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $2.39M $471K -$12K -2.48% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-06
Q2 2025 $2.41M $644K +$53K +8.97% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-07
Q1 2025 $2.35M $435K -$720K -62.3% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-13
Q4 2024 $3.07M $844K +$421K +99.5% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-13
Q3 2024 $2.65M $483K +$132K +37.6% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-06
Q2 2024 $2.52M $591K +$279K +89.4% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-07
Q1 2024 $2.24M $1.16M +$843K +270% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-13
Q4 2023 $1.4M $423K Oct 1, 2023 Dec 31, 2023 10-K 2025-03-13
Q3 2023 $351K +$314K +849% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $312K +$116K +59.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $312K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q3 2022 $37K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $196K Apr 1, 2022 Jun 30, 2022 10-Q/A 2023-08-14

INTENSITY THERAPEUTICS, INC. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $3.07M +$1.68M +120% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-13
2023 $1.4M +$229K +19.6% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-13
2022 $1.17M Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.